EarningsQ4 2024 Earnings Report

Novo Nordisk (NVON) Q4 2024 Earnings Report

1 Followers

MX:NVON Q4 2024 EPS Results

Actual EPS$16.17

Consensus EPS$15.17

Beat/MissBeat by +$1.00

One Year Ago EPS$13.07

Actual Revenue$223.68B

Expected Revenue$203.27B

Beat/MissBeat by +$20.41B

YoY Revenue Growth+29.05%

QuarterQ4 2024

Date02/05/2025

TimeBefore Open

Conference CallWednesday, February 5, 2025

MX:NVON Upcoming Earnings

Novo Nordisk's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:NVON Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	13.54 / -	12.632	―
Aug 04, 2026	2026 (Q2)	14.06 / 17.43	16.958	2.80% (+0.47)
May 06, 2026	2026 (Q1)	16.14 / 19.04	18.163	4.82% (+0.88)
Feb 04, 2026	2025 (Q4)	16.85 / 17.41	16.173	7.67% (+1.24)
Nov 05, 2025	2025 (Q3)	13.95 / 12.63	16.082	-21.45% (-3.45)
Aug 06, 2025	2025 (Q2)	16.78 / 16.96	12.011	41.19% (+4.95)
May 07, 2025	2025 (Q1)	16.70 / 18.16	14.859	22.24% (+3.30)
Feb 05, 2025	2024 (Q4)	15.17 / 16.17	13.07	23.74% (+3.10)
Nov 06, 2024	2024 (Q3)	16.06 / 16.08	12.979	23.91% (+3.10)
Aug 07, 2024	2024 (Q2)	12.92 / 12.01	11.646	3.13% (+0.37)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed